For example, increased expression of AURKA was correlated with worse survival in 16 of the 33 cancer types including KIRP (log-rank p = 3.41 × 10−8, KICH (log-rank p = 5.20 × 10−6), and KIRC (log-rank p = 1.11 × 10−10) (Figure 6B); increased expression of PTEN was correlated with better survival in 6 cancer types including LGG (log-rank p = 4.44 × 10−9), KIRC (log-rank p = 4.21 × 10−3), LIHC (log-rank p = 2.64 × 10−2), UCEC (log-rank p = 4.25 × 10−5), PRAD (log-rank p = 7.07 × 10−2) and LAML (log-rank p = 3.64 × 10−2) (Figure 6B). This evidence concerns the gene PTEN and cancer.